Literature DB >> 8492942

Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease.

P M Matthews1, B Ford, R J Dandurand, D H Eidelman, D O'Connor, A Sherwin, G Karpati, F Andermann, D L Arnold.   

Abstract

We followed 16 patients with a variety of mitochondrial diseases over one to four periods of treatment (2 months each) with coenzyme Q10 plus vitamins K3 and C, riboflavin, thiamine, and niacin, using independent measures of oxidative metabolism to assess efficacy. There were large (> threefold) increases in serum coenzyme Q10 concentrations with treatment, but no measure of oxidative metabolism showed significant improvement with treatment for the group, nor did any individual patient show significant, reproducible, objective clinical improvement. The results suggest that coenzyme Q10 plus vitamin therapy does not significantly improve mitochondrial oxidative metabolism in patients with mitochondrial disease in general. Any clinical benefit that may follow from short-term administration appears slight.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8492942     DOI: 10.1212/wnl.43.5.884

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Why are there no proven therapies for genetic mitochondrial diseases?

Authors:  Peter W Stacpoole
Journal:  Mitochondrion       Date:  2011-05-13       Impact factor: 4.160

Review 2.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Metabolic interventions against complex I deficiency in MELAS syndrome.

Authors:  K Majamaa; H Rusanen; A Remes; I E Hassinen
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

Review 4.  Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Authors:  Emanuela Bottani; Costanza Lamperti; Alessandro Prigione; Valeria Tiranti; Nicola Persico; Dario Brunetti
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

5.  Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy.

Authors:  B Barbiroli; R Medori; H J Tritschler; T Klopstock; P Seibel; H Reichmann; S Iotti; R Lodi; P Zaniol
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

6.  Mitochondrial disease patients' perception of dietary supplements' use.

Authors:  Amel Karaa; Joshua Kriger; Johnston Grier; Amy Holbert; John L P Thompson; Sumit Parikh; Michio Hirano
Journal:  Mol Genet Metab       Date:  2016-07-16       Impact factor: 4.797

7.  Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease.

Authors:  Juan Garrido-Maraver; Mario D Cordero; Irene Domínguez Moñino; Sheila Pereira-Arenas; Ana V Lechuga-Vieco; David Cotán; Mario De la Mata; Manuel Oropesa-Ávila; Manuel De Miguel; Juan Bautista Lorite; Eloy Rivas Infante; Manuel Alvarez-Dolado; Plácido Navas; Sandra Jackson; Silvia Francisci; José A Sánchez-Alcázar
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 8.  Adverse effects of antiretroviral therapy for HIV infection.

Authors:  Valentina Montessori; Natasha Press; Marianne Harris; Linda Akagi; Julio S G Montaner
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262

9.  Biochemical monitoring of the treatment in paediatric patients with mitochondrial disease.

Authors:  R Artuch; M A Vilaseca; M Pineda
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

10.  Mitochondrial Dysfunction and Chronic Disease: Treatment With Natural Supplements.

Authors:  Garth L Nicolson
Journal:  Integr Med (Encinitas)       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.